4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Moleculin Biotech, Inc. (MBRX) operates in the Biotechnology industry and is headquartered in Houston, United States with about 17 employees. Its market capitalization is roughly $15 million. In the fiscal year ended 2025-12-31, MBRX reported $0M in revenue and ($34M) in net income.
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($25M) | ($27M) | ($30M) | ($31M) |
| Net Income | ($34M) | ($26M) | ($30M) | ($29M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($8M) | ($8M) | ($6M) | ($6M) | ($6M) |
| Net Income | ($13M) | $16M | ($25M) | ($8M) | ($6M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $22M | $17M | $38M | $57M | — |
| Total Liabilities | $7M | $6M | $12M | $5M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MBRX viewer.
About TickerBase · Data methodology & sources